Stockreport

Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF Manufacturing equipment and related assets to be sold to Catalent’s Paragon Gene Therapy for $18 million in cashOver 100 manufacturing and quality employees to join Cata [Read more]